JDVCX
Price
$16.51
Change
+$0.19 (+1.16%)
Updated
Aug 22 closing price
Net Assets
476.78M
RLBCX
Price
$37.31
Change
+$0.41 (+1.11%)
Updated
Aug 22 closing price
Net Assets
253.63B
Interact to see
Advertisement

JDVCX vs RLBCX

Header iconJDVCX vs RLBCX Comparison
Open Charts JDVCX vs RLBCXBanner chart's image
JPMorgan Diversified C
Price$16.51
Change+$0.19 (+1.16%)
VolumeN/A
Net Assets476.78M
American Funds American Balanced R3
Price$37.31
Change+$0.41 (+1.11%)
VolumeN/A
Net Assets253.63B
JDVCX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JDVCX vs. RLBCX commentary
Aug 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDVCX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 254B vs. JDVCX (477M). JDVCX pays higher dividends than RLBCX: JDVCX (1.88) vs RLBCX (1.56). JDVCX was incepted earlier than RLBCX: JDVCX (22 years) vs RLBCX (23 years). JDVCX (1.74) is less costly to investors than RLBCX (0.89). JDVCX is a more actively managed with annual turnover of: 63.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than JDVCX: RLBCX (250) vs JDVCX (1000). RLBCX annual gain was more profitable for investors over the last year : 7.65 vs. JDVCX (6.22). RLBCX return over 5 years is better than : 36.74 vs. JDVCX (3.95).
JDVCXRLBCXJDVCX / RLBCX
Total Expense Ratio1.460.89164%
Annual Report Gross Expense Ratio1.740.89196%
Fund Existence22 years23 years-
Gain YTD8.0559.89081%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets477M254B0%
Annual Yield % from dividends1.881.56121%
Returns for 1 year6.227.6581%
Returns for 3 years21.9232.3068%
Returns for 5 years3.9536.7411%
Returns for 10 years17.8075.5624%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NWPX52.691.82
+3.59%
NWPX Infrastructure Inc
DBD63.091.73
+2.82%
Diebold Nixdorf
ICLR175.830.13
+0.07%
ICON plc
ENTX1.94-0.01
-0.51%
Entera Bio Ltd
RKDA4.09-0.26
-5.98%
Arcadia Biosciences